169 related articles for article (PubMed ID: 8275357)
1. The effects of the aminobisphosphonate alendronate on thyroid hormone-induced osteopenia in rats.
Yamamoto M; Markatos A; Seedor JG; Masarachia P; Gentile M; Rodan GA; Balena R
Calcif Tissue Int; 1993 Oct; 53(4):278-82. PubMed ID: 8275357
[TBL] [Abstract][Full Text] [Related]
2. The aminobisphosphonate alendronate inhibits bone loss induced by thyroid hormone in the rat. Comparison between effects on tibiae and vertebrae.
Balena R; Markatos A; Gentile M; Masarachia P; Seedor JG; Rodan GA; Yamamoto M
Bone; 1993; 14(3):499-504. PubMed ID: 8363899
[TBL] [Abstract][Full Text] [Related]
3. Alendronate prevents cyclosporin A-induced osteopenia in the rat.
Sass DA; Bowman AR; Yuan Z; Ma Y; Jee WS; Epstein S
Bone; 1997 Jul; 21(1):65-70. PubMed ID: 9213009
[TBL] [Abstract][Full Text] [Related]
4. Beneficial effects of combined administration of alendronate and alfacalcidol on cancellous bone mass of the tibia in orchidectomized rats: a bone histomorphometry study.
Iwamoto J; Takeda T; Matsumoto H; Sato Y; K Yeh J
J Nutr Sci Vitaminol (Tokyo); 2008 Feb; 54(1):11-7. PubMed ID: 18388402
[TBL] [Abstract][Full Text] [Related]
5. Do different aminobisphosphonates have similar preventive effect on experimental thyroid hormone-induced osteopenia in rats?
Zeni S; Gomez-Acotto C; Mautalen C
Calcif Tissue Int; 2001 Nov; 69(5):305-10. PubMed ID: 11768202
[TBL] [Abstract][Full Text] [Related]
6. Effects of tiludronate on bone mass, structure, and turnover at the epiphyseal, primary, and secondary spongiosa in the proximal tibia of growing rats after sciatic neurectomy.
Murakami H; Nakamura T; Tsurukami H; Abe M; Barbier A; Suzuki K
J Bone Miner Res; 1994 Sep; 9(9):1355-64. PubMed ID: 7529459
[TBL] [Abstract][Full Text] [Related]
7. Alendronate distributed on bone surfaces inhibits osteoclastic bone resorption in vitro and in experimental hypercalcemia models.
Azuma Y; Sato H; Oue Y; Okabe K; Ohta T; Tsuchimoto M; Kiyoki M
Bone; 1995 Feb; 16(2):235-45. PubMed ID: 7756053
[TBL] [Abstract][Full Text] [Related]
8. Preclinical pharmacology of alendronate.
Rodan GA; Seedor JG; Balena R
Osteoporos Int; 1993; 3 Suppl 3():S7-12. PubMed ID: 8298203
[TBL] [Abstract][Full Text] [Related]
9. Short-term prevention of osteoclastic resorption and osteopenia in ovariectomized rats treated with the H(2) receptor antagonist cimetidine.
Lesclous P; Guez D; Saffar JL
Bone; 2002 Jan; 30(1):131-6. PubMed ID: 11792575
[TBL] [Abstract][Full Text] [Related]
10. The effects of bone remodeling inhibition by alendronate on three-dimensional microarchitecture of subchondral bone tissues in guinea pig primary osteoarthrosis.
Ding M; Danielsen CC; Hvid I
Calcif Tissue Int; 2008 Jan; 82(1):77-86. PubMed ID: 18175032
[TBL] [Abstract][Full Text] [Related]
11. Inhibited osteoclastic bone resorption through alendronate treatment in rats reduces severe osteoarthritis progression.
Siebelt M; Waarsing JH; Groen HC; Müller C; Koelewijn SJ; de Blois E; Verhaar JA; de Jong M; Weinans H
Bone; 2014 Sep; 66():163-70. PubMed ID: 24933343
[TBL] [Abstract][Full Text] [Related]
12. The role of subchondral bone remodeling in osteoarthritis: reduction of cartilage degeneration and prevention of osteophyte formation by alendronate in the rat anterior cruciate ligament transection model.
Hayami T; Pickarski M; Wesolowski GA; McLane J; Bone A; Destefano J; Rodan GA; Duong LT
Arthritis Rheum; 2004 Apr; 50(4):1193-206. PubMed ID: 15077302
[TBL] [Abstract][Full Text] [Related]
13. Pharmacodynamic responses to combined treatment regimens with the calcium sensing receptor antagonist JTT-305/MK-5442 and alendronate in osteopenic ovariectomized rats.
Fisher JE; Scott K; Wei N; Zhao JZ; Cusick T; Tijerina M; Karanam B; Duong L; Glantschnig H
Bone; 2012 Jun; 50(6):1332-42. PubMed ID: 22445539
[TBL] [Abstract][Full Text] [Related]
14. The effects of 2-year treatment with the aminobisphosphonate alendronate on bone metabolism, bone histomorphometry, and bone strength in ovariectomized nonhuman primates.
Balena R; Toolan BC; Shea M; Markatos A; Myers ER; Lee SC; Opas EE; Seedor JG; Klein H; Frankenfield D
J Clin Invest; 1993 Dec; 92(6):2577-86. PubMed ID: 8254015
[TBL] [Abstract][Full Text] [Related]
15. A rat model of thyroid hormone-induced bone loss: effect of antiresorptive agents on regional bone density and osteocalcin gene expression.
Kung AW; Ng F
Thyroid; 1994; 4(1):93-8. PubMed ID: 8054866
[TBL] [Abstract][Full Text] [Related]
16. Effects of alendronate and strontium ranelate on cancellous and cortical bone mass in glucocorticoid-treated adult rats.
Sun P; Cai DH; Li QN; Chen H; Deng WM; He L; Yang L
Calcif Tissue Int; 2010 Jun; 86(6):495-501. PubMed ID: 20390406
[TBL] [Abstract][Full Text] [Related]
17. Effect of alendronate administration on bone mineral density and bone strength in castrated rats.
Broulik PD; Rosenkrancová J; Růzicka P; Sedlácek R
Horm Metab Res; 2005 Jul; 37(7):414-8. PubMed ID: 16034712
[TBL] [Abstract][Full Text] [Related]
18. Alendronate increases skeletal mass of growing rats during unloading by inhibiting resorption of calcified cartilage.
Bikle DD; Morey-Holton ER; Doty SB; Currier PA; Tanner SJ; Halloran BP
J Bone Miner Res; 1994 Nov; 9(11):1777-87. PubMed ID: 7863829
[TBL] [Abstract][Full Text] [Related]
19. Pre-emptive, early, and delayed alendronate treatment in a rat model of knee osteoarthritis: effect on subchondral trabecular bone microarchitecture and cartilage degradation of the tibia, bone/cartilage turnover, and joint discomfort.
Mohan G; Perilli E; Parkinson IH; Humphries JM; Fazzalari NL; Kuliwaba JS
Osteoarthritis Cartilage; 2013 Oct; 21(10):1595-604. PubMed ID: 23827368
[TBL] [Abstract][Full Text] [Related]
20. Alendronate influences bending force of femoral diaphysis after orchidectomy in rats.
Huuskonen J; Arnala I; Olkkonen H; Alhava E
Ann Chir Gynaecol; 2001; 90(2):109-14. PubMed ID: 11459259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
